NPM1 and acute myeloid leukemia: However, in HOXA-expressing AML, such as AML with NPM1 or MLL gene mutations, RIPK3 signaling is activated, which promotes such AML development by repressing the differentiation of leukemic cells via inhibition of JAK1-STAT1 signaling (Xin et al., 2016b).